Multi-stage mechanisms of tumor metastasis and therapeutic strategies

Z Liu, J Chen, Y Ren, S Liu, Y Ba, A Zuo… - … and Targeted Therapy, 2024 - nature.com
The cascade of metastasis in tumor cells, exhibiting organ-specific tendencies, may occur at
numerous phases of the disease and progress under intense evolutionary pressures. Organ …

Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy

CA Shirley, G Chhabra, D Amiri, H Chang… - Frontiers in …, 2024 - frontiersin.org
Melanoma is one of the most lethal neoplasms of the skin. Despite the revolutionary
introduction of immune checkpoint inhibitors, metastatic spread, and recurrence remain …

CAR NK cell therapy for the treatment of metastatic melanoma: Potential & prospects

W Hibler, G Merlino, Y Yu - Cells, 2023 - mdpi.com
Melanoma is among the most lethal forms of cancer, accounting for 80% of deaths despite
comprising just 5% of skin cancer cases. Treatment options remain limited due to the genetic …

[HTML][HTML] Unveiling the dynamic interplay between cancer stem cells and the tumor microenvironment in melanoma: implications for novel therapeutic strategies

P Limonta, R Chiaramonte, L Casati - Cancers, 2024 - mdpi.com
Simple Summary Resistance to standard therapies represents a major challenge in
melanoma treatment. This is mainly related to the high heterogeneity of this malignancy due …

Trametinib-Resistant Melanoma Cells Displaying MITFhigh/NGFRlow/IL-8low Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and …

P Koziej, K Kluszczynska, ML Hartman… - International Journal of …, 2023 - mdpi.com
Despite significant advances in targeted therapies against the hyperactivated
BRAFV600/MEK pathway for patients with unresectable metastatic melanoma, acquired …

Molecular and spatial signatures of human and rat corpus cavernosum physiopathological processes at single-cell resolution

Y Yin, Y Chen, J Xu, B Liu, Y Zhao, X Tan, M Xiao… - Cell Reports, 2024 - cell.com
The composition and cellular heterogeneity of the corpus cavernosum (CC)
microenvironment have been characterized, but the spatial heterogeneity at the molecular …

[HTML][HTML] Lipids in the tumor microenvironment: immune modulation and metastasis

G Pascual, SA Benitah - Frontiers in Oncology, 2024 - pmc.ncbi.nlm.nih.gov
Tumor cells can undergo metabolic adaptations that support their growth, invasion, and
metastasis, such as reprogramming lipid metabolism to meet their energy demands and to …

Promising approach for targeting ROBO1 with CAR NK cells to combat ovarian cancer primary tumor cells and organoids

Y Zhu, L Wang, B Jiang, Y Wang, Q Wu, S Hong… - Future Science …, 2024 - Taylor & Francis
Aim: This study aimed to explore using peripheral blood mononuclear cell (PBMC)-derived
chimeric antigen receptor (CAR) NK cells targeting ROBO1 as a personalized medicine …

[HTML][HTML] Nebivolol, an antihypertensive agent, has new application in inhibiting melanoma

S Yang, Z Li, J Yi, M Pan, W Cao, J Ma… - Anti-Cancer …, 2024 - journals.lww.com
Repurposing existing drugs for cancer therapy has become an important strategy because
of its advantages, such as cost reduction, effect and safety. The present study was designed …

Lipids in the tumor microenvironment: immune modulation and metastasis

G Pascual Angulo, S Aznar Benitah - Frontiers In Oncology, 2024, 14 …, 2024 - diposit.ub.edu
Tumor cells can undergo metabolic adaptations that support their growth, invasion, and
metastasis, such as reprogramming lipid metabolism to meet their energy demands and to …